Literature DB >> 11431198

AN-69 membrane reactions are pH-dependent and preventable.

P D Brophy1, T A Mottes, T L Kudelka, K D McBryde, J J Gardner, N J Maxvold, T E Bunchman.   

Abstract

We report two pediatric patients who required blood priming for continuous venovenous hemodiafiltration. Both of these patients developed a significant hypotensive episode with initiation of continuous venovenous hemodiafiltration with immediate resolution on discontinuation. The most notable common characteristics of these patients were the use of the Multi-flo 60 (AN-69) dialyzer membrane and blood priming. No similar episodes were encountered when patients were primed with saline or albumin. The AN-69 membrane is exquisitely pH sensitive. The lower the pH concentration of the blood passing by the membrane, the greater the activation of bradykinin, a known hypotensive-inducing agent, by the dialyzer. On review of blood available from our blood bank, the following parameters became apparent. The pH of standard blood available from our blood bank ranged from 6.1 to 6.4. The blood obtained from our blood bank had significant hyperkalemia, hyponatremia, and hypocalcemia. No reactions were noted when patients were primed with normal saline, which has a pH of around 5.9. We speculate that the presence of endogenous blood substances, such as bradykinin, may have induced the hypotensive episodes. We describe two techniques we developed that should allow for the increased safe and effective use of the AN-69 membranes in continuous venovenous hemodiafiltration circuits. These observations indicate the requirement for careful and close attention to detail when delivering renal replacement therapy to anyone, but especially patients weighing less than 10 kg.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11431198     DOI: 10.1053/ajkd.2001.25212

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  14 in total

Review 1.  Controversies in paediatric continuous renal replacement therapy.

Authors:  Graeme Maclaren; Warwick Butt
Journal:  Intensive Care Med       Date:  2009-01-31       Impact factor: 17.440

2.  Phenylacetate and benzoate clearance in a hyperammonemic infant on sequential hemodialysis and hemofiltration.

Authors:  Timothy E Bunchman; Gina-Marie Barletta; John W Winters; John J Gardner; Teri L Crumb; Kevin D McBryde
Journal:  Pediatr Nephrol       Date:  2007-02-03       Impact factor: 3.714

3.  Molecular Absorbent Recirculating System therapy (MARS®) in pediatric acute liver failure: a single center experience.

Authors:  Pierre Bourgoin; Aicha Merouani; Véronique Phan; Catherine Litalien; Michel Lallier; Fernando Alvarez; Philippe Jouvet
Journal:  Pediatr Nephrol       Date:  2013-12-06       Impact factor: 3.714

4.  Continuous hemofiltration in the control of neonatal hyperammonemia: a 10-year experience.

Authors:  Claire Westrope; Kevin Morris; David Burford; Gavin Morrison
Journal:  Pediatr Nephrol       Date:  2010-05-22       Impact factor: 3.714

5.  Zero balance ultrafiltration (Z-BUF) in blood-primed CRRT circuits achieves electrolyte and acid-base homeostasis prior to patient connection.

Authors:  Richard M Hackbarth; Dawn Eding; Carla Gianoli Smith; Ada Koch; Dominic J Sanfilippo; Timothy E Bunchman
Journal:  Pediatr Nephrol       Date:  2005-06-10       Impact factor: 3.714

6.  Use of HF20 membrane in critically ill unstable low-body-weight infants on inotropic support.

Authors:  Isaac Desheng Liu; Kar-Hui Ng; Perry Yew-Weng Lau; Wee-Song Yeo; Pei-Lin Koh; Hui-Kim Yap
Journal:  Pediatr Nephrol       Date:  2013-01-11       Impact factor: 3.714

7.  Pre dialysis of blood prime in continuous hemodialysis normalizes pH and electrolytes.

Authors:  Deborah A Pasko; Theresa A Mottes; Bruce A Mueller
Journal:  Pediatr Nephrol       Date:  2003-10-02       Impact factor: 3.714

8.  Hemodynamic instability during connection to continuous kidney replacement therapy in critically ill pediatric patients.

Authors:  Sameer Thadani; Thomas Fogarty; Theresa Mottes; Jack F Price; Poyyapakkam Srivaths; Cynthia Bell; Ayse Akcan-Arikan
Journal:  Pediatr Nephrol       Date:  2022-02-03       Impact factor: 3.651

Review 9.  Dialysis and pediatric acute kidney injury: choice of renal support modality.

Authors:  Scott Walters; Craig Porter; Patrick D Brophy
Journal:  Pediatr Nephrol       Date:  2008-05-16       Impact factor: 3.714

10.  Complications of continuous renal replacement therapy in critically ill children: a prospective observational evaluation study.

Authors:  Maria J Santiago; Jesús López-Herce; Javier Urbano; María José Solana; Jimena del Castillo; Yolanda Ballestero; Marta Botrán; Jose María Bellón
Journal:  Crit Care       Date:  2009-11-23       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.